Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: Experience of the German Testicular Cancer Study Group

Journal of Urology

Volumn 169, Issue 5, 2003, Pages 1710-1714

  Heidenreich, Axel ^a   Albers, Peter ^a   Hartmann, Michael ^a   Kliesch, Sabine ^a   Köhrmann, Kai Uwe ^a   Krege, Susanne ^a   Lossin, Philipp ^a   Weissbach, Lothar ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Germinomas; Lymph node dissection; Neoplasm metastases; Testes

Indexed keywords

ABDOMINAL WALL HERNIA; ADULT; ARTERY LESION; ARTICLE; CANCER STAGING; CHYLOUS ASCITES; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; EPIDIDYMITIS; FOLLOW UP; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; KELOID; LENGTH OF STAY; LUNG EMBOLISM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MAJOR CLINICAL STUDY; MORBIDITY; NERVE SPARING RETROPERITONEAL LYMPH NODE DISSECTION; OPERATION DURATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; STOMACH ULCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR RECURRENCE; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 0037404227     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000060960.18092.54     Document Type: Article

References (20)

1. Foster, R. S. and Donohue, J. P.: Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma. J Urol, 163: 1788, 2000
2. Richie, J. P. and Kanthoff, P. W.: Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol, 9: 1393, 1991
3. Rabbani, F., Sheinfeld, J., Farivar-Mohseni, H., Leon, A., Rentzepis, M. J., Reuter, V. E. et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol, 19: 2020, 2001
4. Krege, S., Souchon, R., and Schmoll, H. J.: Interdisciplinary consensus on the diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM). Eur Urol, 40: 372, 2001
5. Babaian, R. J., Bracken, R. B. and Johnson, D. E.: Complications of transabdominal retroperitoneal lymphadenectomy. Urology, 17: 126, 1981
6. Skinner, D. G., Melamud, A. and Lieskovsky, G.: Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol, 127: 1107, 1982
7. Baniel, J., Foster, R. S., Rowland, R. G., Bihrle, R. and Donohue, J. P.: Complications of primary retroperitoneal lymph node dissection. J Urol, 152: 424, 1994
8. Jewett, M. A. S., Kong, Y.-S. P., Goldberg, S. D., Sturgeon, J. F. G., Thomas, G. M., Alison, R. E. et al: Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol, 139: 1220, 1988
9. Donohue, J. P., Foster, R. S., Rowland, R. G., Birhle, R., Jones, J. and Geier, G.: Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol, 144: 287, 1990
10. Studer, U. E., Burkhard, F. C. and Sonntag, R. W.: Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage I nonseminomatous germ cell tumor. J Urol, 163: 1785, 2000
11. Baniel, J., Foster, R. S., Einhorn, L. E. and Donohue, J. P.: Late relapse of clinical stage I testicular cancer. J Urol, 154: 1370, 1995
12. Hendry, W. F., Norman, A., Nicholls, J., Dearnaley, D. P., Peckham, M. J. and Horwich, A.: Abdominal relapse in stage I nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy. BJU Int, 86: 89, 2000
13. Roeleveld, T. A., Horenblas, S., Meinhardt, W., van de Vijver, M., Kooi, M. and ten Bokkel Huinink, W. W.: Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients. J Urol, 166: 2166, 2001
14. Heidenreich, A. and Hofmann, R.: Molecular pathogenesis and prognosis in human testicular germ cell tumors. Eur Urol, 37: 121, 2000
15. Albers, P., Ulbright, T. M., Albers, J., Miller, G. A., Orazi, A., Crabtree, W. N. et al: Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. J Urol, 155: 579, 1996
16. Heidenreich, A., Sesterhenn, I. A., Mostofi, F. K. and Moul, J. W.: Prognostic factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and at high risk for metastasis. Cancer, 83: 1002, 1998
17. Sharir, S., Foster, R. S., Jewett, M. A. S., Sturgeon, J. F. G., Moore, M. and Donohue, J. R.: Optimizing follow up for early stage nonseminomatous testicular cancer. J Urol, suppl., 155: 327A, abstract 67, 1996
18. Sweeney, C. J., Hermans, B. P., Heilmann, D. K., Foster, R. S., Donohue, J. P. and Einhorn, L. H.: Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer. J Clin Oncol, 18: 358, 2000
19. Cespedes, R. D. and Peretsman, S. J.: Retroperitoneal recurrences after retroperitoneal lymph node dissection for low-stage nonseminomatous germ cell tumors. Urology, 54: 548, 1999
20. Janetschek, G.: Laparoscopic retroperitoneal lymph node dissection. Urol Clin North Am, 28: 107, 2001